Off-the-shelf human stem cell therapy

Naturally Pluripotent Amniotic Fluid Stem Cells

Leveraging 10+ years of authoritative research

Founder, Dr. Bruce K. Young's research at NYU has opened a pathway to the development of regenerative medicine

Turning a waste product into stem cells

With a patented process to collect cells, process them, and package them frozen within 48 hours for direct clinical use

A stem cell therapy platform

Unlocking the power of cell therapy for a wide variety of indications at scale

No genetic modification required

Our cells can treat any patient, with no laboratory work neccessary, significantly lowering risks to the patient, and significantly reducing costs

Our research has positioned us as pre-eminent experts in
the field of Amniotic Fluid Stem Cells

Now our team is commercializing this research into a product

Meet Our Team

Image of Dr. Joaquim Trias
Dr. Joaquim TriasExecutive Chairman
Veteran biotech founder with 7 exits, including 4 Nasdaq IPOs and 3 acquisitions to Johnson & Johnson and Pfizer. He has extensive experience in discovery and development of several drugs in clinical development. He has extensively published on antibiotic resistance, and has multiple patents on antibiotic discovery. He holds a Ph.D. from the University of Barcelona, Spain, and did a postdoctoral stage at the University of California, Berkeley.
Image of Dr. Michael Chen
Dr. Bruce K. YoungFounder & CEO
Formerly a Professor of Obstetrics and Gynecology at NYU Grossman School of Medicine. Dr. Young developed the technology and has published scientific reports on stem cell biology in peer-reviewed journals. He is internationally known as a scientific and clinical innovator as well as a leader in Obstetrics and Gynecology. He will design and supervise the clinical trials for FDA approval of the product.
Image of Sarah Rodriguez
Dr. James CooperChief Science Officer
Professor of Medicine, Assistant Dean of Georgetown University School of Medicine with over 20 years experience in clinical research with numerous scientific presentations and publications. Founder and Chairman of Theragnostic Health, with successful exit.
Image of Alexandra Lee
Dr. Peter WeinsteinChief Counsel
Leading intellectual property, transaction, and corporate law. He received his Juris Doctorate degree at Boston College Law School, and his Ph.D. in Biology with an emphasis in Immunology from the University of Pennsylvania. Dr. Weinstein is a registered patent attorney and is licensed to practice law in California and is admitted to the U.S. District Court for the Central and Southern Districts of California.
Image of Sarah Rodriguez
Caroline EinauglerCo-Founder
Associate Professor at Rutgers Law School with 15 years of practical experience in information science in both the medical and legal fields. She is an experienced business leader and a founder and marketing SVP of profitable start-up Jurisearch. She has hired, built and directed many high performing teams in successful business areas.
Image of Alexandra Lee
Tom SharonCo-Founder
Silicon Valley technology executive who has founded and led Y Combinator, Softbank, and Sequoia backed startups. Formerly a Product Manager at Google. Leading operations for Amnicell.